Drug Pricing

California

Health Care Needs Effective Reforms, Not the CREATES Act

Congress is back in session. With the election looming, this means a frenetic dash to pass bills on a number of big ticket items, including the budget and Zika funding. While the legislative fight over these issues will likely dominate the headlines, we cannot forget about other below-the-radar, but nevertheless ...
Commentary

Need A Roadmap For Healthcare Reform? Look At Medicare Part D

Paul Ryan and his House Republican colleagues just released their much-anticipated plan to reform America’s healthcare system. Their 37-page proposal would, among other things, transform Medicare into a “premium support” program. Seniors would be able to use federal subsidies to buy their choice of health plans from private insurers, instead ...
California

The high price of “cheap” drugs

California is losing the battle against opioid addiction. Every 45 minutes, someone in the Golden State overdoses. Fifty percent more people overdose today than in 2006. Fortunately, the Food and Drug Administration just approved the anti-addiction treatment Probuphine. It’s an implant placed in a person’s upper arm, where it releases ...
Business & Economics

Who’s Afraid of Anti-Inversion Rules?

Swift and merciless. That was the apparent effect the U.S. Treasury’s April 4 regulatory package had on what was poised to be the largest inversion in history. But several pending inversions have emerged relatively unscathed, and experts are predicting continued corporate exodus, raising questions about what exactly Treasury has accomplished. ...
Commentary

Trump and Obama promise to be terrible negotiators

President Barack Obama and presidential hopeful Donald Trump don’t agree on much. But they’ve found common ground in pushing to upend the Medicare drug benefit. At a rally days before his resounding victory in New Hampshire, Trump grumbled about government drug spending — and called for Medicare to take over ...
Commentary

Hillary’s Price Controls Would Kill New Drug Innovation

Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
Commentary

To control drug prices, pursue fraud, not manufacturers

A Los Angeles-based nonprofit has gathered enough signatures to get two initiatives on the November ballot. The one of greater interest to ordinary Californians would legislate that any prescription drug paid for with state money cost no more than the amount paid by the Veterans Administration. The California Drug Price ...
Commentary

Clinton would drive up health care costs

Five years and nine months after its passage, the federal government has issued more than 10,000 pages of regulations related to the implementation of Obamacare. Get ready for several thousand more pages if Hillary Clinton takes the White House. She’s proposing a raft of new government mandates to “protect the ...
Commentary

The Senate should reject foreign drug importation

Congress must send a budget to President Obama by next Friday. Senate lawmakers, hoping to avoid a government shutdown, have just started sparring over the details of their reconciliation measure. Sen. John McCain (R-Ariz.) has introduced an amendment to legalize the importation of certain prescription drugs from abroad. On the ...
Commentary

Pharmaceutical Price Controls Risk Future Cures

Recent reports of significant price increases for certain medications have ignited, yet again, calls for pharmaceutical price controls. If implemented, price controls will reduce medical discovery and diminish patients’ access to life saving medicines. Pharmaceutical innovations help patients and strengthen the U.S. economy Pharmaceutical innovations are improving the quality of ...
California

Health Care Needs Effective Reforms, Not the CREATES Act

Congress is back in session. With the election looming, this means a frenetic dash to pass bills on a number of big ticket items, including the budget and Zika funding. While the legislative fight over these issues will likely dominate the headlines, we cannot forget about other below-the-radar, but nevertheless ...
Commentary

Need A Roadmap For Healthcare Reform? Look At Medicare Part D

Paul Ryan and his House Republican colleagues just released their much-anticipated plan to reform America’s healthcare system. Their 37-page proposal would, among other things, transform Medicare into a “premium support” program. Seniors would be able to use federal subsidies to buy their choice of health plans from private insurers, instead ...
California

The high price of “cheap” drugs

California is losing the battle against opioid addiction. Every 45 minutes, someone in the Golden State overdoses. Fifty percent more people overdose today than in 2006. Fortunately, the Food and Drug Administration just approved the anti-addiction treatment Probuphine. It’s an implant placed in a person’s upper arm, where it releases ...
Business & Economics

Who’s Afraid of Anti-Inversion Rules?

Swift and merciless. That was the apparent effect the U.S. Treasury’s April 4 regulatory package had on what was poised to be the largest inversion in history. But several pending inversions have emerged relatively unscathed, and experts are predicting continued corporate exodus, raising questions about what exactly Treasury has accomplished. ...
Commentary

Trump and Obama promise to be terrible negotiators

President Barack Obama and presidential hopeful Donald Trump don’t agree on much. But they’ve found common ground in pushing to upend the Medicare drug benefit. At a rally days before his resounding victory in New Hampshire, Trump grumbled about government drug spending — and called for Medicare to take over ...
Commentary

Hillary’s Price Controls Would Kill New Drug Innovation

Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
Commentary

To control drug prices, pursue fraud, not manufacturers

A Los Angeles-based nonprofit has gathered enough signatures to get two initiatives on the November ballot. The one of greater interest to ordinary Californians would legislate that any prescription drug paid for with state money cost no more than the amount paid by the Veterans Administration. The California Drug Price ...
Commentary

Clinton would drive up health care costs

Five years and nine months after its passage, the federal government has issued more than 10,000 pages of regulations related to the implementation of Obamacare. Get ready for several thousand more pages if Hillary Clinton takes the White House. She’s proposing a raft of new government mandates to “protect the ...
Commentary

The Senate should reject foreign drug importation

Congress must send a budget to President Obama by next Friday. Senate lawmakers, hoping to avoid a government shutdown, have just started sparring over the details of their reconciliation measure. Sen. John McCain (R-Ariz.) has introduced an amendment to legalize the importation of certain prescription drugs from abroad. On the ...
Commentary

Pharmaceutical Price Controls Risk Future Cures

Recent reports of significant price increases for certain medications have ignited, yet again, calls for pharmaceutical price controls. If implemented, price controls will reduce medical discovery and diminish patients’ access to life saving medicines. Pharmaceutical innovations help patients and strengthen the U.S. economy Pharmaceutical innovations are improving the quality of ...
Scroll to Top